Vitrafy Life Sciences Stock Performance
- Closing Price (12:41 PM Central Europe, Monday 26 Feb 2026): AUD 2.48
- Daily Change: –4.15 %
- 24‑Hour Volume: AUD 114.2 k
- Current Market Capitalisation: AUD 193.6 mn
- Shares Outstanding: 76.2 mn
- 52‑Week High: AUD 4.66 (17 Aug 2026)
- 52‑Week Low: AUD 1.28 (6 Jan 2026)
- Simple Moving Average (200 days): AUD 2.67
- Month‑End Trend: –26.16 % from the previous month’s close
Upcoming Corporate Disclosure
Vitrafy Life Sciences Limited has announced that it will release its Q1 FY2027 Quarterly Activities Report, along with an accompanying appendix, on 28 October 2026. The release will follow a brief statement issued by the company’s secretary.
An investor briefing is scheduled for 9:30 AM AEDT on the same day. The session will be presented via a webinar, and shareholders as well as prospective investors are invited to attend through a registration link. Investors are encouraged to submit questions beforehand to the Investor Relations team.
The briefing will highlight the company’s proprietary cryopreservation hardware, Guardion, and the cloud‑based LifeChain™ platform. These technologies are positioned as a cohesive system for maintaining biomaterial integrity across multiple sectors.
24‑Hour Performance of Related Stocks
| Ticker | Change (24 hrs) | Current Price (AUD) | Market Capitalisation (AUD mn) | P/E Ratio |
|---|---|---|---|---|
| MMI.AX (Metro Mining) | –4 % | 0.70 | 222.1 | 116.39 |
| ASG.AX (Autosports) | +0.94 % | 1.06 | 228.0 | 8.05 |
| SXL.AX (Southern Cross Media L) | –2.97 % | 0.48 | 229.8 | – |
| BGD.AX (Barton Gold) | +1.20 % | 0.81 | 227.7 | – |
| SPL.AX (Starpharma) | –1.06 % | 0.48 | 228.8 | – |
All figures are current as of the 24‑hour period ending at the specified time.
